Riltrava Aerosphere (formoterol fumarate dihydrate/glycopyrronium/budesonide)
/ AstraZeneca
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 16, 2021
CHMP recommends 11 new medicines for authorization, including two COVID-19 monoclonal antibodies
(Regulatory Affairs Professionals Society)
- "AstraZeneca was granted a positive opinion for its informed consent application for Riltrava Aerosphere (formoterol fumarate dihydrate/glycopyrronium/budesonide) for treating chronic obstructive pulmonary disease in adults whose disease is not adequately controlled by other medications."
European regulatory • Chronic Obstructive Pulmonary Disease • Respiratory Diseases
1 to 1
Of
1
Go to page
1